Aoquan Bio (奥全生物)

上海奥全生物-首页

Shanghai, China · Founded 2019 · $14.9M raised

Headquarters
Shanghai
Employees
11–50
Founded
2019
Business Model
B2B
Total Funding
$14.9M
Last Round
$14.9M Series BAug 2022
Rounds
1

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Shanghai Aoquan Biomedical Technology Co., Ltd. (Aoquan Bio) is an international biopharmaceutical company founded in 2019, dedicated to the R&D and industrialization of high-end improved formulations for unmet clinical needs. The company focuses on targeted drug improvements in pediatrics, vascular diseases, and antiviral fields, developing new dosage forms, new indications, and new dosing regimens approved by both the US FDA and China NMPA. Its R&D center is based in Pudong, Shanghai, with a US subsidiary Auson Pharmaceuticals Inc. in New Jersey handling product commercialization in North America.

Summary

Aoquan Bio (奥全生物) is a Biotech company based in Shanghai, China, founded in 2019. It has raised $14.9M in total across 1 round, most recently a $14.9M Series B round in Aug 2022. Investors include Deyi Capital and Kaitai Capital.

Tech & App Stack

1 technology or app tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BAug 2022
$14.9M

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Aoquan Bio (奥全生物) on Indexed.vc
<a href="https://indexed.vc/companies/aoquan-bio"><img src="https://indexed.vc/api/badge/company/aoquan-bio" alt="Aoquan Bio (奥全生物) on Indexed.vc" width="260" height="76" /></a>